← Back to patent-cliff list
[18F]BF3-BPA
Tier C — Watch / trade[18F]BF3-BPA
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
In vivo diagnostic
Type
Targets：LAT1
Indications (approved)：脑癌, 脑部造影剂
Regional status
US
-
EU
-
China
Phase II
2026-08-18
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of [18F]BF3-BPA?
Approved indications include: 脑癌, 脑部造影剂.
When does the [18F]BF3-BPA patent expire?
No public expiry year is available for [18F]BF3-BPA yet; this page updates once verified.
How do I get a quote for [18F]BF3-BPA intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29